We have located links that may give you full text access.
Rational Design of GO-Modified Fe 3 O 4 /SiO 2 Nanoparticles with Combined Rhenium-188 and Gambogic Acid for Magnetic Target Therapy.
ACS Applied Materials & Interfaces 2017 August 31
Peanutlike magnetic-fluorescent Fe3 O4 /SiO2 nanoparticles, with an effective dynamic diameter of 180 nm, were synthesized via EuO+ doping and coupling of two Fe3 O4 cores and reassembling through the solvothermal process. Spherical pure Fe3 O4 /SiO2 nanoparticles with an effective dynamic diameter of 230 nm were also prepared for comparison. We designed graphene oxide (GO)-modified core-shell Fe3 O4 /SiO2 nanoparticles as a nanocarrier for loading gambogic acid (GA) following labeling with radioisotope rhenium-188. We also performed GA loading and releasing on GA-loaded magnetic nanoparticles, in vivo biodistribution, and magnetic drug targeting therapy experiments. Results indicated that the GA-loaded magnetic nanoparticles demonstrate a clear pH-dependent drug release behavior, having a higher release rate in acidic environments. The in vivo biodistribution of the magnetic nanoparticles has morphologic dependency, and the peanutlike nanoparticles (PN-Fe3 O4 ) tend to accumulate more in the spleen, lung, and liver than in the spherical nanoparticles (S-Fe3 O4 ). The targeted therapy showed a higher efficacy of PN-Fe3 O4 in inhibiting tumor cell growth than the nontargeted therapy. The polyethyleneimine (PEI) grafting of PN-Fe3 O4 with amide bond was also designed to find an effective active targeting antitumor agent considering the fact that the PEI-GO conjugate has a higher GA load efficiency and the convergence effect.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app